Amneal Pharmaceuticals, Inc. - News - Press Releases

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 18, 2007

Amneal Completes Acquisition of Liquid Form Generic Pharmaceuticals Manufacturing Plant

Dec 17, 2007

IMPAX Announces FDA Acceptance of ANDA for Generic Version of Opana(R) ER

Dec 06, 2007

IMPAX Submits Additional Information to FDA Related to ANDA For Generic Version of Opana(R) ER

Nov 27, 2007

Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process

Nov 27, 2007

IMPAX to Reinitiate Sales of Limited Quantity of Generic OxyContin(R)

Nov 19, 2007

IMPAX Comments on Lawsuit Related to Generic Version of Opana(R) ER

Oct 18, 2007

Amneal & Indoco Remedies Finalize Long Term Joint Venture to Develop and Market Generic Ophthalmic Pharmaceuticals

Oct 18, 2007

IMPAX Announces Tentative Approval of Generic Effexor XR(R)

Oct 04, 2007

IMPAX Comments on Status of ANDA for Generic Opana(R) ER

Sep 27, 2007

FTC Challenges Mylan’s Proposed Acquisition of Merck’s Generic Subsidiary

Sep 17, 2007

Amneal Pharmaceuticals Profile in Chain Drug Review

Aug 15, 2007

IMPAX Names Larry Hsu as CEO Effective October 1, 2006

Jul 27, 2007

IMPAX Announces Ruling Related to Generic Rilutek(R)

Jul 25, 2007

IMPAX Achieves Milestone in Efforts to File Delinquent Periodic Reports

Jun 19, 2007

IMPAX Announces Lawsuit Related to Generic Version of Depakote ER

Jun 08, 2007

IMPAX Presents at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders

Jun 01, 2007

IMPAX Announces Decision on Generic Prilosec(R) Litigation

May 31, 2007

Amneal Announces Acquisition of Akyma Pharmaceuticals

May 29, 2007

IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets

May 25, 2007

IMPAX Announces Dismissal of Generic OxyContin Litigation

May 22, 2007

IMPAX Seeks SEC Review of Initial Decision

May 16, 2007

IMPAX to Present at the Citigroup 2007 Healthcare Conference

May 09, 2007

IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg

May 01, 2007

IMPAX Reports SEC Actions

Apr 03, 2007

IMPAX Announces FDA Approval of Generic Corzide

Apr 02, 2007

IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals

Mar 14, 2007

IMPAX to Present at the Lehman Brothers 10th Annual Global Healthcare Conference

Mar 05, 2007

IMPAX Settles Patent Litigation Related to Generic Wellbutrin(R) XL

Feb 02, 2007

IMPAX Files Revised Submission with Office of the Chief Accountant of the SEC

Jan 31, 2007

IMPAX to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Jan 18, 2007

IMPAX Files Amendment to Vadova(TM) NDA

Jan 02, 2007

IMPAX Reports SEC Actions

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.103.0.4